Article info
PDFLetter
Identifying the proportion of age related macular degeneration patients who would benefit from photodynamic therapy with verteporfin (Visudyne)
- Correspondence to: Nakul Mandal, c/o Sheila Davies, Southampton Eye Unit, Southampton SO16 6YD, UK; nm397{at}soton.ac.uk
Citation
Identifying the proportion of age related macular degeneration patients who would benefit from photodynamic therapy with verteporfin (Visudyne)
Publication history
- Accepted July 25, 2001
- First published January 1, 2002.
Online issue publication
January 23, 2023
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2002 British Journal of Ophthalmology